Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

sal32647 13 posts  |  Last Activity: Apr 27, 2016 1:51 PM Member since: Nov 23, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • fullsensitivity • Apr 26, 2016 1:25 PM Flag

    3
    users liked this posts

    users disliked this posts
    0
    Reply
    .

    There is good and less good here dankdamp. J&J will no doubt lose their en banc request. When they do, it will end the ruling/appeal/appeal process. The Federal Circuit is at the end of the line. Once the en banc is denied there will be a Mandate by the Federal Circuit within 3 weeks. That is the end of the end.

    J&J can appeal to the Supreme Court, but that will not stop the Mandate from issuing. Less

    fullsensitivity • Apr 26, 2016 1:25 PM Flag

    3
    users liked this posts

    users disliked this posts
    0
    Reply
    .

  • Type messagePerhaps the company and their legal team are more knowledgeable.

    I sincerely doubt a high powered legal team would take on a cash strapped company with no immediate prospects and with no hope of recouping their investment in time and effort.

    Berman quote:

    Quote:
    The company's nationally prominent patent legal counsel, responsible for a series of conclusive successive legal victories over the last three years against J&J/Lifescan, has strongly recommended pursuit of this legal action after extensive review of all the related patents. It is their informed opinion and that of other experts that J&J/Lifescan's patent violations are so clear and so egregious that there is no other course for our companies to pursue. The companies have filed for, and are entitled to, a court awarded compensation of at least $400 million, and perhaps as much as $700 million.

    Yes, I understand this case is a different issue from the ongoing court actions of the past 4 some years, but the backers of DECN during those 4 years are also (I am sure) confident their monies will be recouped (many times over).

    Why would they have funded DECN if they were not confident of a favorable outcome?



    Discover Advanced Options Trading on E*TRADE Pro. Open an Account Today.

  • Reply to

    Why insiders not buying...

    by sal32647 Apr 1, 2016 1:13 PM
    sal32647 sal32647 Apr 1, 2016 2:18 PM Flag

    It's too bad that some newbies are scared from buying, they will have to chase, they can blame the bashers for losing out. imo.

  • Quote from Alydyr on other board.
    "WHY NO INSIDER BUYING?"

    My answer was deleted on the other board. Insiders most likely have inside information and that isn't known to the public at this time. They can't buy or they would be breaking the law.

  • Ksviking, I also like the GenUltimate product is ready for commercial sale. Will begin advertising the product the second week in April 2016.

  • Reply to

    Summary Judgement denied

    by mattchad21 Mar 8, 2016 9:06 PM
    sal32647 sal32647 Mar 11, 2016 1:41 PM Flag

    Alydyr, who are you working for? Must pay well, you're on these boards a lot. imo.

  • If I was short I'd be getting worried about now. imo.

    Sentiment: Strong Buy

  • Reply to

    Good read...

    by sal32647 Feb 17, 2016 12:19 PM
    sal32647 sal32647 Feb 17, 2016 1:01 PM Flag

    Support bid and buy ask in small amounts, to get buyers to come in. imo.

  • sal32647 by sal32647 Feb 17, 2016 12:19 PM Flag

    How it works

    This process can be used by hedge funds to either pump up a stock or to trash a stock but since I am using Herbalife as an example, we will discuss that situation. First information is widely distributed to make investors wonder about the company and to put fear into those longs that hold the stock. Next, high volume shorting takes place to drive the company's share price down.

    As the short attack continues, more people parade out news to continue to put questions in the back of investors' minds. On a daily basis, shorts use computerized trading to control the direction of the share price. At opportune times, the shorts overwhelm the buyers (bid price) of the stock by selling short large number of shares to drive the share price down and to eliminate the buyers for the stock at that given time. For people who are not familiar with the bid/ask process of trading stocks, here is a link to explain that process.

    Shorts need to control the stock's share price over a long time (often several months to well over a year), and can't afford to just accumulate an unlimited number of short positions in the stock, so they have to be buying shares at the same time they are selling shares too. When the shorts drive the share price down, eliminating buyers as discussed above, some of those investors trying to sell their shares at that same time will follow the share price activity downward lowering their ask price.

    Now the shorts can buy back some of the shares they have shorted at lower prices including some shares where longs have put stop-loss sale orders to protect against downside losses. The shorts will only buy shares part of the way back up as the share price rises, and then wait to see if new buyers come into the market. If the share price continues to rise up to much again during the day, the shorts will repeat the same selling and buying process to control the share price.

    As mentioned above, the shorts need to control the share price over an extended period of time. They need to wear down the longs with rumor mongering as well as by creating fear as the longs continue to see the share price go down from the computerized trading. They hope the longs will give up and sell their shares at the lowest possible share price.

    Another observation, shorts try to wear down the longs by making sure that the share price closes down as many days in a row as they can put together. At the close of each day, I witnessed volume dramatically increasing as the shorts tried to insure Herbalife's share price closed down. Shorts are hoping the longs frustration with the share price continuing downward will end up in capitulation where as many longs as possible just give up and sell their shares.

  • Re: None
    Post # of 28328

    Just n FYI: The JNJ board has many more DECN posts than any other board. Check it out. The posts are very positive for DECN!!! Including other companies now looking to follow DECN's lead and bring JNJ to court.

    The (current) same board of directors has voted in favor of dividends in the past (December 2011) This same board has, in the past, voted down inadequate merger proposals from NASDAQ listed companies. These guys seem to manage the situation better than most. Since 2012 the board has only issued new shares to cover litigation costs. With just a 47.5M share (current float) and a guaranteed minimum 17.5M check coming; this is an easy buy and hold winner.

    I am expecting some very exciting news for shareholders soon. I am holding long... very long. After the dust settles; we will see how this takes off. Check out the DECN website: the job opportunities are currently posted... including the project manager position to oversee the East Asia manufacturing plant.

    Open an account at E*TRADE today.

  • Quote:
    We have won so conclusively that the Federal Circuit Court took the uncommon step of awarding us court costs in their Rule 36 decision. That award punctuated their decision and emphasized their conviction in the ruling. We would like to thank all of our shareholders who have supported our efforts and fought the battle with us. We are fully committed to shortly rewarding their patience, investment and encouragement."

  • Reply to

    Posted this on other board...

    by sal32647 Feb 9, 2016 10:00 AM
    sal32647 sal32647 Feb 9, 2016 11:16 AM Flag

    I agree

  • Now they are after the bond money plus other damages. Wait and see what happens to the share price when J&J is ordered to pay the bond money alone, then what happens when they are ordered to pay for damages. People will be chasing at much higher price if they don't get in soon. imo.

AFFY
0.0821-0.0079(-8.78%)Apr 29 12:01 PMEDT